| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.24 | 6e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |